Skip to main content
. 2022 Nov 14;10(6):e02808-22. doi: 10.1128/spectrum.02808-22

TABLE 5.

Performance with clinical specimens

Target Result TORa pos TOR neg Overall agreement PPAb (95% CI) NPAc (95% CI)
AP Fusion Pos 49 0 98.8% (93.3%–99.8%) 98.0% (89.5%–99.6%) 100% (88.7%–100.0%)
Fusion Neg 1 30
BM Fusion Pos 45 0 100% (95.1%–100.0%) 100.0% (92.1%–100.0%) 100% (88.7%–100.0%)
Fusion Neg 0 30
EC Fusion Pos 30 0 100% (95.4%–100.0%) 100% (88.7%–100.0%) 100% (92.9%–100.0%)
Fusion Neg 0 50
a

Test of record (TOR).

b

Positive Percent Agreement (PPA).

c

Negative Percent Agreement (NPA).